Literature DB >> 15721107

Relation of CD39 to plaque instability and thrombus formation in directional atherectomy specimens from patients with stable and unstable angina pectoris.

Kinta Hatakeyama1, Hiroyuki Hao, Takuroh Imamura, Tetsunori Ishikawa, Yoshisato Shibata, Yoshihiro Fujimura, Tanenao Eto, Yujiro Asada.   

Abstract

To determine whether the expression of CD39 in coronary atherosclerotic lesions is related to plaque instability and thrombus formation, we assessed directional coronary atherectomy (DCA) specimens from patients with stable and unstable angina pectoris. CD39 immunoreactivity was decreased in culprit lesions in patients with unstable angina pectoris compared with those with stable angina pectoris, and was reduced in DCA specimens with thrombus formation. These results suggest that CD39 expressed in atheromatous plaque plays an important role in preventing acute coronary syndromes.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15721107     DOI： 10.1016/j.amjcard.2004.11.012

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Interventional procedures for atherothrombosis: pathology of retrieved material.

Authors:  Annalisa Angelini; Mila Della Barbera; Gaetano Thiene
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

2.  Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

Authors:  Zachary M Huttinger; Michael W Milks; Michael S Nickoli; William L Aurand; Lawrence C Long; Debra G Wheeler; Karen M Dwyer; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  Am J Pathol       Date:  2012-05-18       Impact factor: 4.307

3.  Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.

Authors:  Roman Covarrubias; Elena Chepurko; Adam Reynolds; Zachary M Huttinger; Ryan Huttinger; Katherine Stanfill; Debra G Wheeler; Tatiana Novitskaya; Simon C Robson; Karen M Dwyer; Peter J Cowan; Richard J Gumina
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

4.  Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

Authors:  Jan David Hohmann; Xiaowei Wang; Stefanie Krajewski; Carly Selan; Carolyn A Haller; Andreas Straub; Elliot L Chaikof; Harshal H Nandurkar; Christoph E Hagemeyer; Karlheinz Peter
Journal:  Blood       Date:  2013-02-04       Impact factor: 22.113

Review 5.  CD39: Interface between vascular thrombosis and inflammation.

Authors:  Yogendra M Kanthi; Nadia R Sutton; David J Pinsky
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

6.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.

Authors:  Simon C Robson; Jean Sévigny; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

Review 7.  Thrombus Formation and Propagation in the Onset of Cardiovascular Events.

Authors:  Yujiro Asada; Atsushi Yamashita; Yuichiro Sato; Kinta Hatakeyama
Journal:  J Atheroscler Thromb       Date:  2018-06-09       Impact factor: 4.928

Review 8.  Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques.

Authors:  Yujiro Asada; Atsushi Yamashita; Yuichiro Sato; Kinta Hatakeyama
Journal:  Pathol Int       Date:  2020-03-13       Impact factor: 2.534

9.  Chlamydia pneumoniae is Prevalent in Symptomatic Coronary Atherosclerotic Plaque Samples Obtained From Directional Coronary Atherectomy, but its Quantity is Not Associated With Plaque Instability: An Immunohistochemical and Molecular Study.

Authors:  Tomoyuki Otani; Kensaku Nishihira; Yoshinao Azuma; Atsushi Yamashita; Yoshisato Shibata; Yujiro Asada; Kinta Hatakeyama
Journal:  Clin Pathol       Date:  2022-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.